Faraday Pharmaceuticals' Series A - II Round

Faraday Pharmaceuticals raised a round of funding on February 21, 2017.

Faraday Pharmaceuticals is a biopharmaceutical company focusing on the research and development of elemental reducing agents. These therapeutic agents have potential applications for treatment of crit…

Articles about Faraday Pharmaceuticals' Series A - II Round: